The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Gestational Diabetes, Pregnancy Hypertension, and Late Vascular Disease
Abstract
The complexity of the several pathogenic pathways that cause hypertension and vascular disease and the prolonged interval that appears to predate clinical morbidity have hindered inquiry into the association between GDM and vascular disorders. As a forme fruste of later type 2 diabetes, GDM-affected gravidas are identified as at risk of diabetes-related atherosclerosis, glomerular disruption, and pathogenic retinal angio-genesis. That GDM is evidence for underlying chronic conditions such as dysregulation of innate immune response that, independent of the diabetic state, produces vascular disease is difficult state, produces vascular disease is difficult to assert with the present published literature. Cross-sectional studies of patients with established gestational hypertension or preeclampsia are ambiguous as to the possible pathogenic effect of insulin resistance. Cohort studies initiated in early and mid-pregnancy show evidence that both gestational hypertension and preeclampsia may be more prevalent in gravidas with greater insulin resistance. The association of gestational glucose intolerance with gestational hypertension appears to be independent of obesity and ambient glycemia but explained in part by insulin resistance. Late pregnancy preeclampsia is associated with elevated mid-pregnancy BMI, blood pressure, fasting glucose and insulin, urate, and C-reactive protein, suggestive of metabolic and immune dysregulation. GDM appears to be associated with overexpressed innate immune response, which, in turn, is associated with vascular dysfunction and vascular disease. Among women with GDM, markers of insulin resistance do not appear to correlate with hypertension in short-term cohort studies. However, when non-GDM subjects are compared with subjects with GDM, postpregnancy studies do show an associated with vascular dysfunction and vascular disease. Among women with GDM, markers of insulin resistance do not appear to correlate with hypertension in short-term cohort studies. However, when non-GDM subjects are compared with subjects with GDM, postpregnancy studies do show an association of insulin resistance with both inflammatory dysregulation and vascular dysfunction. Cohort studies that have used population-based pregnancy databases consistently identify a clinically significant association of both gestational hypertension and preeclampsia with later hypertensive disorders. Associations with coronary artery disease or stroke are less consistent, requiring further investigation. Preventing the evolution of diabetes and lipid and immune dysregulation of the metabolic syndrome has become a silent public health issue because of the epidemic of childhood and early adulthood obesity and the opportunity at hand to treat insulin resistance by behavioral and pharmacological interventions. However, limited available literature highlights the need for long-term cohort studies of women with well-characterized metabolic and vascular profiles during pregnancy and decades later. Our present knowledge suggests that screening for GDM provides an opportunity of pregnancy outcome improvement. Limited studies of diabetes prevention in at-risk patient groups suggest that we may have the opportunity to reduce the risk of later diabetes. Additional investigation is required to determine if interventions that prevent or postpone diabetes also delay the onset of vascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Wilson, B. J., Watson, M. S., Prescott, G. J., Sunderland, S., Campbell, D. M., Hannaford, P., & Smith, W. C. S. (2003) · BMJ · doi:10.1136/bmj.326.7394.845 · Cited by 723
Hypertensive disorders in pregnancy
CHESLEY, L. (1985) · Journal of Nurse-Midwifery · doi:10.1016/0091-2182(85)90116-8 · Cited by 630
Sermer, M., Naylor, C. D., Gare, D. J., Kenshole, A. B., Ritchie, J. W. K., Farine, D., Cohen, H. R., McArthur, K., Holzapfel, S., Biringer, A., et al. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90183-3 · Cited by 510
Association between Gestational Diabetes and Pregnancy-induced Hypertension
Bryson, C. L. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg273 · Cited by 273
Cardiovascular sequelae of toxaemia of pregnancy.
Hannaford, P., Ferry, S., & Hirsch, S. (1997) · Heart · doi:10.1136/hrt.77.2.154 · Cited by 251
C-Reactive Protein and Gestational Diabetes: The Central Role of Maternal Obesity
Retnakaran, R., Hanley, A. J. G., Raif, N., Connelly, P. W., Sermer, M., & Zinman, B. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030186 · Cited by 243
Evidence of a state of increased insulin resistance in preeclampsia
Kaaja, R., Laivuori, H., Laakso, M., Tikkanen, M. J., & Ylikorkala, O. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90225-1 · Cited by 228
First Trimester Insulin Resistance and Subsequent Preeclampsia: A Prospective Study
Wolf, M., Sandler, L., Muñoz, K., Hsu, K., Ecker, J. L., & Thadhani, R. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.4.1563 · Cited by 221
Joffe, G. M., Esterlitz, J. R., Levine, R. J., Clemens, J. D., Ewell, M. G., Sibai, B. M., & Catalano, P. M. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70210-8 · Cited by 210
Heitritter, S. M., Solomon, C. G., Mitchell, G. F., Skali-Ounis, N., & Seely, E. W. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2494 · Cited by 191
Impaired Endothelium-Dependent Vasodilatation in Women With Previous Gestational Diabetes
Anastasiou, E., Lekakis, J. P., Alevizaki, M., Papamichael, C. M., Megas, J., Souvatzoglou, A., & Stamatelopoulos, S. F. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2111 · Cited by 188
Temelkova-Kurktschiev, T. S., Siegert, G., Bergmann, S., Henkel, E., Koehler, C., Jaroszlig, W., & Markolf Hanefeld, E. (2002) · Metabolism · doi:10.1053/meta.2002.32804 · Cited by 155
Glucose intolerance as a predictor of hypertension in pregnancy.
Solomon, C. G., Graves, S. W., Greene, M. F., & Seely, E. W. (1994) · Hypertension · doi:10.1161/01.hyp.23.6.717 · Cited by 136
Abnormal Carbohydrate Metabolism During Pregnancy
Paradisi, G., Biaggi, A., Ferrazzani, S., Carolis, S. D., & Caruso, A. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.560 · Cited by 114
Hyperinsulinemia and insulin resistance are associated with preeclampsia in African-Americans
Sowers, J. R., SALEH, A., & SOKOL, R. (1995) · American Journal of Hypertension · doi:10.1016/0895-7061(94)00166-9 · Cited by 90
Factors predisposing to pre-eclampsia in women with gestational diabetes
Barden, A. E., Singh, R., Walters, B. N. J., Ritchie, J., Roberman, B. D., & Beilin, L. J. (2004) · Journal of Hypertension · doi:10.1097/00004872-200412000-00020 · Cited by 85
Caruso, A., Ferrazzani, S., Carolis, S. D., Lucchese, A., Lanzone, A., Santis, L. D., & Paradisi, G. (1999) · Human Reproduction · doi:10.1093/humrep/14.1.219 · Cited by 79
Bergholm, R., Tiikkainen, M., Vehkavaara, S., Tamminen, M., Teramo, K. A., Rissanen, A., & Yki‐Järvinen, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1667 · Cited by 70
Insulin Resistance and Preeclampsia in Gestational Diabetes Mellitus
Montoro, M. N., Kjos, S. L., Chandler, M., Peters, R. K., Xiang, A. H., & Buchanan, T. A. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.1995 · Cited by 56
Hyperinsulinemia increases the risk of gestational hypertension
Hamasaki, T., Yasuhi, I., Hirai, M., Masuzaki, H., & Ishimaru, T. (1996) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(96)02759-2 · Cited by 28
Emery, S. P., Levine, R. J., Qian, C., Ewell, M., England, L. J., Yu, K., Catalano, P. M., & for the CPEP Study Group (2005) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2005.00720.x · Cited by 24
Midpregnancy Serum C-Peptide Concentration and Subsequent Pregnancy-Induced Hypertension
Yasuhi, I., Hogan, J. W., Canick, J. A., Sosa, M. E. B., & Carpenter, M. W. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.743 · Cited by 17
Self-citation
Research works printed but not linked: 1
- Cioffi FJ, Amorosa LF, Vintzileos AM, Lai YK, Lake MF, Gregory PM, Rifici VA: Relationship of insulin resistance and hyperinsulinemia to blood pressure duirng pregnancy. J Matern Fetal Med 6:174–179, 1997 · doi:10.1002/(sici)1520-6661(199705/06)6:3<174::aid-mfm11>3.0.co;2-i
Cited by
Lee, K. W., Ching, S. M., Ramachandran, V., Yee, A., Hoo, F. K., Chia, Y. C., Wan Sulaiman, W. A., Suppiah, S., Mohamed, M. H., & Veettil, S. K. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-2131-4 · Cited by 546
Gestational diabetes mellitus: an updated overview
Chiefari, E., Arcidiacono, B., Foti, D., & Brunetti, A. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0607-5 · Cited by 522
Ryckman, K., Spracklen, C., Smith, C., Robinson, J., & Saftlas, A. (2015) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13261 · Cited by 402
Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring
METZGER, B. E. (2007) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e31815a61d6 · Cited by 297
Langley‐Evans, S. C., Pearce, J., & Ellis, S. (2022) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12999 · Cited by 288
Metadata
- Authors
- Carpenter, M. W.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2007-07-01
- Volume
- 30
- Issue
- Supplement_2
- Pages
- S246-S250
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2119934592
- Cited by
- 282
- References
- 23
- FWCI
- 13.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.